SubHero Banner
Text

Zirabev (bevacizumab-bvzr) – New biosimilar approval

June 28, 2019 - Pfizer announced the FDA approval of Zirabev (bevacizumab-bvzr), a biosimilar to Genentech’s Avastin® (bevacizumab).

Download PDF